DeepCure

Reimagining small molecule therapies for immune diseases

Boston, United States · Founded 2018 · $64.6M raised

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$64.6M
Last Round
$24.6M Series AApr 2024
Rounds
2

About

DeepCure's proprietary PocketExpander technology uses AI and physics-based methods, including quantum mechanical and molecular dynamics simulations, to identify physical and chemical features on protein surfaces that can interact with small molecules — enabling it to pursue targets with no known ligand and design molecular glues. Its MolGen molecular generation tool uses deep reinforcement learning to build readily synthesizable compound libraries meeting ADME-Tox and target candidate profile requirements. DiscoveryHub, its collaboration platform, lets structural biologists, computational chemists, AI engineers, medicinal chemists and biologists share data across the design-make-test-analyze cycle.

Summary

DeepCure is an Artificial Intelligence company based in Boston, United States, founded in 2018. It has raised $64.6M in total across 2 rounds, most recently a $24.6M Series A round in Apr 2024.

Funding History

Series ASeries AApr 2024
$24.6M

Sign up to see all 2 rounds

Series A — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DeepCure on Indexed.vc
<a href="https://indexed.vc/companies/deepcure"><img src="https://indexed.vc/api/badge/company/deepcure" alt="DeepCure on Indexed.vc" width="260" height="76" /></a>